We are live on
!
Find out more
HITK
HI-TECH PHARMACAL INC
HITK
HITK
Delisted
HITK was delisted on the 16th of April, 2014.
105 hedge funds and large institutions have $413M invested in HI-TECH PHARMACAL INC in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 28
26% more capital invested
Capital invested by funds: $329M → $413M (+$84.6M)
19% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 21
4% more funds holding
Funds holding: 101 → 105 (+4)
4% more call options, than puts
Call options by funds: $660K | Put options by funds: $634K
Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
3.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
39
Reduced
28
Closed
21
Calls
$660K
Puts
$634K
Net Calls
+$26K
Net Calls Change
-$4.27M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$38.5M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.6M |
| 3 |
Morgan Stanley
New York
|
+$13M |
| 4 |
Millennium Management
New York
|
+$11.6M |
| 5 |
JP Morgan Chase
New York
|
+$10.2M |
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$64.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.8M |
| 3 |
O
OrbiMed
New York
|
-$12.3M |
| 4 |
BC
Broadfin Capital
New York
|
-$9.07M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.24M |
